Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Hughes report published by the Patient Safety Commissioner on 7 February 2024, if he will take steps to introduce a compensation scheme which is open to (a) all UK and (b) Northern Ireland patients affected by sodium valproate.

The Government is carefully considering the valuable work done by the Patient Safety Commissioner and the resulting Hughes Report, which set out options for redress for those harmed by valproate and pelvic mesh. We will be providing an update to the Patient Safety Commissioner’s report at the earliest opportunity. Although the Hughes Report and its recommendations only cover patients harmed in England, the Government recognises that any response will likely have implications for the whole of the United Kingdom, and so we will engage with the devolved administrations on the Hughes Report.

Healthcare in Northern Ireland is a devolved matter and, as such, it is respectfully requested that the question on introducing a compensation scheme for individuals harmed by sodium valproate in Northern Ireland be redirected to the Justice Minister for Northern Ireland or the Minister for Health for Northern Ireland, to be handled at a devolved level.